PAH Physician Survey

JRCT ID: jRCT1030240138

Registered date:04/06/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Pulmonary arterial hypertension
• Date of first enrollment: 04/06/2024
• Target sample size: 420
• Study type: Observational
• Intervention(s): NA

Outcome(s)

Primary Outcome

1.Basic characteristics of physicians
2.Basic characteristics of PAH patients from a physician perspective
3.Principles of disease management and treatment regimens
4.Clinical information describing drivers and barriers for the treatment decision

Secondary Outcome

The data will be stratified to generate two subgroups, regularly treating and occasionally treating physicians groups.
Cross tabultion analysis will be performed to identify any factors associated with treatment decision and disease management.

Key inclusion & exclusion criteria

• Age minimum: >= 24age old
• Age maximum: Not applicable

Include criteria

The pilot and main web survey: the study participants must satisfy all of the following inclusion criteria:
1.Physicians who have experienced PAH treatment at least one adult PAH patient (ages 18 years old and over) using PAH-targeted drugs in the last 5 years
2.Physicians who have experienced in prescription and determination of PAH treatment in the last 5 years
3.Physicians are primarily affiliated with the following departments as their current facilities
-Respiratory internal medicine/Cardiovascular internal medicine/Pediatric cardiology/Rheumatology/Internal medicine for connective tissue/Dermatology and specializing in these areas within general internal medicine
4. Physicians who provide informed consent to participate in the study.

Exclude criteria

The pilot and main web survey: the study participants who satisfy any of the following criteria will be excluded from the study.
1.Physicians who have been employed by a pharmaceutical company or have been a consultant of a pharmaceutical company in the last 5 years
2.Physicians who have experienced prescribing PAH-targeted drugs, but no experience in treatment decision in the last 5 years
3.Physicians who have neither experience in prescribing PAH-targeted drugs nor in treatment decision in the last 5 years
4.Physicians are primarily affiliated with the following departments as their current facilities;
-Neurology/Ophthalmology: specializing in these areas within general internal medicine

Related Information

• Primary Sponsor: Arai Yoko